Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical cardiology"
DOI: 10.1002/clc.23744
Abstract: BACKGROUND Angiotensin receptor neprilysin inhibitor (ARNI) sacubitril-valsartan has been recommended as one of the first-line therapies in heart failure with reduced ejection fraction. However, whether ARNI could benefit patients with ST-segment elevation myocardial infarction (STEMI)…
read more here.
Keywords:
trial;
sacubitril valsartan;
enalapril;
elevation myocardial ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2023-nppg.26
Abstract: Aim The angiotensin-converting enzyme inhibitor, enalapril, is considered a first-line treatment for chronic heart failure in children. However, there is a lack of an age-appropriate formulation and tablet splitting, although not recommended, is common, in…
read more here.
Keywords:
material lost;
enalapril;
tablet;
tablet splitting ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Applied Pharmaceutics"
DOI: 10.22159/ijap.2018v10i4.24528
Abstract: Objective: The main purpose of this study was to develop a simple, precise, rapid and accurate method for the simultaneous quantification of nifedipine and enalapril in human plasma. Methods: Chromatography was achieved on Discovery C18,…
read more here.
Keywords:
human plasma;
method;
enalapril;
enalapril human ... See more keywords